Trial
NCT03310567
A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Recurrent/ Metastatic Endometrial Carcinoma
Intervention
Epacadostat + pembrolizumab
Why stopped
Sponsors pulled out of the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-09